Fenamiphos (Nemacur)

Bayer Corporation announced on March 15, 2002, due to the escalating costs of defending fenamiphos relative to its limited use, Bayer requests voluntary cancellation of all uses of fenamiphos effective May 31, 2005. In addition, Bayer agrees that the FIFRA 6(f) provisions for a 180-day comment period can be waived.